OBJECTIVE: To compare neutralizing antibody response between horses vaccinated against West Nile virus (WNV) and horses that survived naturally occurring infection. DESIGN: Cross-sectional observational study. ANIMALS: 187 horses vaccinated with a killed WNV vaccine and 37 horses with confirmed clinical WNV infection. PROCEDURE: Serum was collected from vaccinated horses prior to and 4 to 6 weeks after completion of an initial vaccination series (2 doses) and 5 to 7 months later. Serum was collected from affected horses 4 to 6 weeks after laboratory diagnosis of infection and 5 to 7 months after the first sample was obtained. The IgM capture ELISA, plaque reduction neutralization test (PRNT), and microtiter virus neutralization test were used. RESULTS: All affected horses had PRNT titers > or = 1:100 at 4 to 6 weeks after onset of disease, and 90% (18/20) maintained this titer for 5 to 7 months. After the second vaccination, 67% of vaccinated horses had PRNT titers > or = 1:100 and 14% had titers < 1:10. Five to 7 months later, 33% (28/84) of vaccinated horses had PRNT titers > or = 1:100, whereas 29% (24/84) had titers < 1:10. Vaccinated and clinically affected horses' end point titers had decreased by 5 to 7 months after vaccination. CONCLUSIONS AND CLINICAL RELEVANCE: A portion of horses vaccinated against WNV may respond poorly. Vaccination every 6 months may be indicated in certain horses and in areas of high vector activity. Other preventative methods such as mosquito control are warranted to prevent WNV infection in horses.
OBJECTIVE: To compare neutralizing antibody response between horses vaccinated against West Nile virus (WNV) and horses that survived naturally occurring infection. DESIGN: Cross-sectional observational study. ANIMALS: 187 horses vaccinated with a killed WNV vaccine and 37 horses with confirmed clinical WNV infection. PROCEDURE: Serum was collected from vaccinated horses prior to and 4 to 6 weeks after completion of an initial vaccination series (2 doses) and 5 to 7 months later. Serum was collected from affected horses 4 to 6 weeks after laboratory diagnosis of infection and 5 to 7 months after the first sample was obtained. The IgM capture ELISA, plaque reduction neutralization test (PRNT), and microtiter virus neutralization test were used. RESULTS: All affected horses had PRNT titers > or = 1:100 at 4 to 6 weeks after onset of disease, and 90% (18/20) maintained this titer for 5 to 7 months. After the second vaccination, 67% of vaccinated horses had PRNT titers > or = 1:100 and 14% had titers < 1:10. Five to 7 months later, 33% (28/84) of vaccinated horses had PRNT titers > or = 1:100, whereas 29% (24/84) had titers < 1:10. Vaccinated and clinically affected horses' end point titers had decreased by 5 to 7 months after vaccination. CONCLUSIONS AND CLINICAL RELEVANCE: A portion of horses vaccinated against WNV may respond poorly. Vaccination every 6 months may be indicated in certain horses and in areas of high vector activity. Other preventative methods such as mosquito control are warranted to prevent WNV infection in horses.
Authors: Bo Xiang; Trevor R Baybutt; Lisa Berman-Booty; Michael S Magee; Scott A Waldman; Vitali Y Alexeev; Adam E Snook Journal: J Immunol Date: 2017-03-24 Impact factor: 5.422
Authors: Stefanie Ganzenberg; Michael Sieg; Ute Ziegler; Martin Pfeffer; Thomas W Vahlenkamp; Uwe Hörügel; Martin H Groschup; Katharina L Lohmann Journal: Viruses Date: 2022-05-30 Impact factor: 5.818
Authors: Nadin N Thompson; Albert J Auguste; Dane Coombs; Bradley J Blitvich; Christine V F Carrington; Amelia P Travassos da Rosa; Eryu Wang; Dave D Chadee; Michael A Drebot; Robert B Tesh; Scott C Weaver; Abiodun A Adesiyun Journal: Vector Borne Zoonotic Dis Date: 2012-09-18 Impact factor: 2.133
Authors: K K Seino; M T Long; E P J Gibbs; R A Bowen; S E Beachboard; P P Humphrey; M A Dixon; M A Bourgeois Journal: Clin Vaccine Immunol Date: 2007-08-08
Authors: Julie L Dutton; Bo Li; Wai-Ping Woo; Joshua O Marshak; Yan Xu; Meei-li Huang; Lichun Dong; Ian H Frazer; David M Koelle Journal: PLoS One Date: 2013-10-03 Impact factor: 3.240